About 2-[[2-(7-bromo-3-oxo-1,4-benzoxazin-4-yl)acetyl]-butan-2-ylamino]acetic acid
2-[[2-(7-bromo-3-oxo-1,4-benzoxazin-4-yl)acetyl]-butan-2-ylamino]acetic acid (PubChem CID 119955263) has the molecular formula C16H19BrN2O5
and a molecular weight of 399.24 g/mol. Its IUPAC name is 2-[[2-(7-bromo-3-oxo-1,4-benzoxazin-4-yl)acetyl]-butan-2-ylamino]acetic acid.
Analyze 2-[[2-(7-bromo-3-oxo-1,4-benzoxazin-4-yl)acetyl]-butan-2-ylamino]acetic acid with MolForge
Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.
Launch Full Analysis
Frequently Asked Questions
What is the IUPAC name of 2-[[2-(7-bromo-3-oxo-1,4-benzoxazin-4-yl)acetyl]-butan-2-ylamino]acetic acid?
The IUPAC name of 2-[[2-(7-bromo-3-oxo-1,4-benzoxazin-4-yl)acetyl]-butan-2-ylamino]acetic acid (CID 119955263) is 2-[[2-(7-bromo-3-oxo-1,4-benzoxazin-4-yl)acetyl]-butan-2-ylamino]acetic acid.
What is the SMILES notation for 2-[[2-(7-bromo-3-oxo-1,4-benzoxazin-4-yl)acetyl]-butan-2-ylamino]acetic acid?
The canonical SMILES for 2-[[2-(7-bromo-3-oxo-1,4-benzoxazin-4-yl)acetyl]-butan-2-ylamino]acetic acid is CCC(C)N(CC(=O)O)C(=O)CN1C(=O)COc2cc(Br)ccc21.
What is the InChIKey of 2-[[2-(7-bromo-3-oxo-1,4-benzoxazin-4-yl)acetyl]-butan-2-ylamino]acetic acid?
The InChIKey is JKXVVNUGGNISCH-UHFFFAOYSA-N. The full InChI is InChI=1S/C16H19BrN2O5/c1-3-10(2)18(8-16(22)23)14(20)7-19-12-5-4-11(17)6-13(12)24-9-15(19)21/h4-6,10H,3,7-9H2,1-2H3,(H,22,23).
What are the key properties of 2-[[2-(7-bromo-3-oxo-1,4-benzoxazin-4-yl)acetyl]-butan-2-ylamino]acetic acid?
2-[[2-(7-bromo-3-oxo-1,4-benzoxazin-4-yl)acetyl]-butan-2-ylamino]acetic acid has a molecular weight of 399.24 g/mol, XLogP of 1.89, 6 rotatable bonds, 1 hydrogen bond donors, and 4 hydrogen bond acceptors.
Where does this data come from?
All data for 2-[[2-(7-bromo-3-oxo-1,4-benzoxazin-4-yl)acetyl]-butan-2-ylamino]acetic acid is sourced from PubChem (CID 119955263), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).